Most Medical Marijuana Patients Stop Or Reduce Pharmaceutical Use With Cannabis, Survey Finds

Most Medical Marijuana Patients Stop Or Reduce Pharmaceutical Use With Cannabis, Survey Finds

Medical marijuana patients generally have more faith in cannabis than the mainstream health care system -

and that’s probably because they’ve found the plant more therapeutically effective compared to traditional pharmaceuticals—according to a new survey.

Researchers distributed about 400 surveys to medical cannabis patients at a pro-reform public event, inquiring about their usage and attitudes toward the U.S. health care system. The results were published this week in the Journal of Psychoactive Drugs.

The participants reported using marijuana for various medical conditions, including chronic pain, muscle spasms, anxiety and post-traumatic stress disorder. Most of them said that cannabis represented an effective and relatively harmless alternative to pharmaceuticals that are conventionally prescribed for their respective conditions.

“In comparison to pharmaceutical drugs, medical cannabis users rated cannabis better on effectiveness, side effects, safety, addictiveness, availability, and cost,” the study found. “Due to the medical use of cannabis, 42 percent stopped taking a pharmaceutical drug and 38 percent used less of a pharmaceutical drug.”

The most common drugs that patients stopped or reduced using were opioid-based painkillers, non-opioid painkillers, benzodiazepines and anti-depressants.

Of course, given the fact that the respondents were participating in a pro-reform advocacy event when they completed the surveys, it could be argued that the results skew in favor of marijuana over pharmaceuticals.

“This study advances knowledge in the evidence-based approach to harm reduction and benefit promotion regarding medical cannabis,” the researchers wrote. “Given the growing use of cannabis for medical purposes and the widespread use for recreation purposes despite criminalization, the current public health framework focusing primarily on cannabis abstinence appears obsolete.”

“Those working in public health and medicine have an obligation to reduce harm and maximize benefits to the health of individuals and society, and thus serious consideration and scientific investigation of medical cannabis are needed,” the study concluded.

SIGN UP FOR NEWS & GET VIP UPDATES

AGE (21+) RESTRICTED PRODUCTS. NO SALES THROUGH THIS SITE. Warning: These products contain cannabis, a Schedule I controlled substance. Keep out of reach of children and animals. Cannabis may only be possessed or consumed by persons 21 years of age or older unless the person is a qualified patient. Cannabis use while pregnant or breastfeeding may be harmful. Consumption of cannabis impairs your ability to drive and operate machinery. Please use extreme caution. California Proposition 65 Warning: Smoking this product will expose you and those in your immediate vicinity to marijuana smoke, a chemical known to the State of California to cause cancer.